CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Curaleaf Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$7.63−0.20 (-2.55%)

Close on Oct 19, 2026

Market cap: $2.07B
P/E (TTM): –
Dividend yield: –

Curaleaf Holdings, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash & Equivalents	89	107	92	163	299	74	42	267
Cash & Short-Term Investments	89	107	92	163	299	74	42	267
Receivables	74	64	60	45	60	29	18	–
Inventory	225	217	216	235	248	198	63	–
Prepaid Expenses & Other	37	28	30	29	36	–	–	–
Other Current Assets	5.90	3.00	–	–	–	–	–	–
Total Current Assets	449	434	419	652	727	418	150	–
Property, Plant & Equipment	520	543	572	596	526	243	130	–
Gross Property, Plant & Equipment	854	803	755	716	603	–	–	–
Accumulated Depreciation	-334	-261	-184	-120	-77	–	–	–
Long-Term Investments	–	–	2.48	2.80	4.40	–	–	–
Operating Lease Right-of-Use Assets	113	116	118	118	76	267	83	–
Goodwill	635	629	627	625	572	539	69	–
Intangible Assets	1,011	1,085	1,172	1,213	1,036	708	186	–
Deferred Tax Assets	0.44	0.40	0.42	1.56	2.16	5.53	2.63	–
Other Long-Term Assets	13	2.95	2.05	15	24	35	8.83	–
Total Assets	2,845	2,950	3,097	3,415	3,105	2,366	737	–
Accounts Payable	75	79	79	81	27	–	–	–
Accrued Expenses	110	102	101	103	87	–	–	–
Current Portion of Long-Term Debt	36	102	39	52	1.97	6.50	17	–
Current Debt	36	102	39	52	1.97	6.50	17	–
Current Portion of Leases	20	17	16	17	13	16	12	–
Current Income Taxes Payable	19	23	198	150	139	80	15	–
Deferred Revenue (Current)	0.63	2.37	0.87	0.68	–	–	–	–
Other Current Liabilities	5.62	0.65	1.26	1.72	12	6.57	32	–
Total Current Liabilities	294	388	494	497	316	220	106	–
Long-Term Debt	513	467	548	571	458	285	88	–
Long-Term Leases	102	106	110	113	65	270	81	–
Operating Lease Liabilities	122	124	126	130	78	289	93	–
Deferred Tax Liabilities	212	245	297	309	258	–	–	–
Other Long-Term Liabilities	1.24	1.13	1.35	0.31	50	3.70	–	–
Total Liabilities	2,005	1,956	1,925	2,014	1,440	985	333	–
Total Debt	549	569	588	623	460	292	105	–
Common Stock	0	2,237	2,204	2,163	2,048	1,754	694	–
Additional Paid-In Capital	2,345	2,237	–	–	–	–	–	–
Retained Earnings	-1,587	-1,356	-1,141	-860	-489	-190	-133	–
Treasury Stock	–	0	-1.05	-5.21	-5.21	-5.21	-5.21	–
Comprehensive Income & Other	-1.81	-20	-12	-19	-6.74	–	–	–
Shareholders' Equity	756	861	1,051	1,280	1,546	1,379	409	–
Total Equity	756	861	1,051	1,280	1,546	1,277	403	436
Total Liabilities & Equity	2,845	2,950	3,097	3,415	3,105	2,366	737	–
Shares Outstanding(shares)	257	250	245	239	236	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 49.8%
Operating margin: 2.0%
Net margin: -18.2%
Return on equity, FY2025: -28.6%

Financial strength

Current ratio: 1.52
Debt to equity: 0.70
Debt to assets: 21.7%
Cash to current liabilities: 30.8%

Valuation

P/E ratio: –
Price to sales: 1.63
Price to book: 2.38
Dividend yield: –